SCHEDULE: Adlai Nortye Ltd. Schedule 13G Ownership Disclosure

Shijun Feng and associated entities disclose a 2.9% beneficial ownership stake in Adlai Nortye Ltd. via Schedule 13G.

Summary

• JIN YIN (BVI) LIMITED, along with its parent entities and Shijun Feng, filed a Schedule 13G reporting beneficial ownership of 4,561,077 Class A ordinary shares of Adlai Nortye Ltd.
• The reported stake represents 2.9% of the total outstanding Class A and Class B ordinary shares as of April 10, 2026.
• The filing confirms that the securities were not acquired for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral regulatory filing that provides transparency regarding existing shareholdings without signaling a change in corporate strategy or market sentiment.

Positives

• Transparent disclosure of beneficial ownership structure involving multiple holding entities.
• Clear chain of control established from the direct holder, JIN YIN (BVI) LIMITED, up to the ultimate beneficial owner, Shijun Feng.

Negatives

• The reporting group holds less than 5% of the company's total outstanding shares, which may limit their influence on corporate governance.

Risks

• Concentration of ownership within a single individual (Shijun Feng) and his controlled entities.
• Potential for future regulatory scrutiny regarding foreign ownership interests in the issuer.

Future Outlook

The filing does not provide forward-looking business guidance, as it is a regulatory disclosure of ownership status.

Management Comments

• The reporting persons certify that the securities were not acquired for the purpose of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that this filing is a standard regulatory requirement for significant shareholders in the biotechnology sector, reflecting the ongoing transparency obligations for investors in U.S.-listed foreign issuers.

Comparison to Industry Standards

• The filing adheres to standard SEC Schedule 13G reporting requirements for passive investors.
• The disclosure structure is consistent with typical ownership reporting for private investment vehicles holding stakes in publicly traded biotech firms.

Related Party Transactions

• The filing discloses a complex ownership structure involving JIN YIN (BVI) LIMITED, Shanghai Gaopei Duwei Biotechnology Co., Ltd., Hangzhou Jingyin Investment Partnership, and Hangzhou Jingfeng Investment Management Company, all ultimately controlled by Shijun Feng.

Stakeholder Impact

• Provides clarity to existing shareholders regarding the concentration of ownership among the reporting group.

Next Steps

• The reporting persons will continue to monitor their ownership stake and file amendments if there are material changes to their holdings.

Key Dates

Keywords

Adlai Nortye, Schedule 13G, Beneficial Ownership, Shijun Feng, Biotechnology, Equity Disclosure